Literature DB >> 22456768

Prevalence and outcome of cirrhosis patients admitted to UK intensive care: a comparison against dialysis-dependent chronic renal failure patients.

Alastair J O'Brien1, Cathy A Welch, Mervyn Singer, David A Harrison.   

Abstract

PURPOSE: Patients with decompensated liver cirrhosis who are admitted to intensive care units (ICU) are perceived, within the UK, as having a particularly poor prognosis.
METHODS: We performed a descriptive analysis of cirrhosis patients admitted to general critical care units 1995-2008 compared to patients admitted with pre-existing chronic renal failure. Data were obtained from the Intensive Care National Audit and Research Centre Case Mix Programme Database incorporating 192 adult critical care units in England, Wales and Northern Ireland.
RESULTS: Cirrhosis accounted for 2.6 % (16,096 patients) of total admissions with mean age 52.5 years and male preponderance (~60 %). Hospital mortality was high (>55 %) although this improved 5 % in recent years, and median length of stay was short (2.5 days). Mortality in cirrhotics with severe sepsis requiring organ support was 65-90 %, compared to 33-39 % in those without. Conversely, patients with chronic renal failure had lower mortality (42 %) despite similar characteristics and higher acute physiology and chronic health evaluation (APACHE) II scores. The APACHE II score under-predicted mortality in cirrhotics.
CONCLUSIONS: Cirrhosis patients exhibit worse outcomes compared to pre-existing renal failure patients, despite similar characteristics. Survival worsens considerably with organ failure, especially with sepsis. They represent a small number of admissions, albeit increasing over recent years, and, in general, have a short ICU stay. Patients with single organ failure have acceptable survival rates and mortality has improved; although we have no data on those refused ICU admission potentially causing survival bias. Given the extremely high mortality in patients with multi-organ failure, support should be limited/withdrawn in such patients.

Entities:  

Mesh:

Year:  2012        PMID: 22456768     DOI: 10.1007/s00134-012-2523-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  38 in total

1.  Spontaneous bacterial peritonitis--in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998.

Authors:  P J Thuluvath; S Morss; R Thompson
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

2.  One year outcome of intensive care patients with decompensated alcoholic liver disease.

Authors:  I J Mackle; D G Swann; B Cook
Journal:  Br J Anaesth       Date:  2006-07-18       Impact factor: 9.166

3.  Prognostic models in cirrhotics admitted to intensive care units better predict outcome when assessed at 48 h after admission.

Authors:  Evangelos Cholongitas; Alex Betrosian; Marco Senzolo; Steve Shaw; David Patch; Pinelopi Manousou; James O'Beirne; Andrew K Burroughs
Journal:  J Gastroenterol Hepatol       Date:  2007-12-13       Impact factor: 4.029

4.  Outcomes of chronic dialysis patients admitted to the intensive care unit.

Authors:  Bradford Strijack; Julie Mojica; Manish Sood; Paul Komenda; Joe Bueti; Martina Reslerova; Dan Roberts; Claudio Rigatto
Journal:  J Am Soc Nephrol       Date:  2009-09-03       Impact factor: 10.121

5.  Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit.

Authors:  E Cholongitas; M Senzolo; D Patch; K Kwong; V Nikolopoulou; G Leandro; S Shaw; A K Burroughs
Journal:  Aliment Pharmacol Ther       Date:  2006-04-01       Impact factor: 8.171

6.  Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.

Authors:  Javier Fernández; Miquel Navasa; Juliá Gómez; Jordi Colmenero; Jordi Vila; Vicente Arroyo; Juan Rodés
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

7.  Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU.

Authors:  A Aggarwal; J P Ong; Z M Younossi; D R Nelson; L Hoffman-Hogg; A C Arroliga
Journal:  Chest       Date:  2001-05       Impact factor: 9.410

8.  Improved survival after variceal bleeding in patients with cirrhosis over the past two decades.

Authors:  Nicolas Carbonell; Arnaud Pauwels; Lawrence Serfaty; Olivier Fourdan; Victor George Lévy; Raoul Poupon
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

9.  Case mix, outcome and activity for patients admitted to intensive care units requiring chronic renal dialysis: a secondary analysis of the ICNARC Case Mix Programme Database.

Authors:  Colin A Hutchison; Alex V Crowe; Paul E Stevens; David A Harrison; Graham W Lipkin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

10.  Case mix, outcome and length of stay for admissions to adult, general critical care units in England, Wales and Northern Ireland: the Intensive Care National Audit & Research Centre Case Mix Programme Database.

Authors:  David A Harrison; Anthony R Brady; Kathy Rowan
Journal:  Crit Care       Date:  2004-02-26       Impact factor: 9.097

View more
  27 in total

1.  Incidence and Outcomes for Patients With Cirrhosis Admitted to the United Kingdom Critical Care Units.

Authors:  Mark J W McPhail; Francesca Parrott; Julia A Wendon; David A Harrison; Kathy A Rowan; William Bernal
Journal:  Crit Care Med       Date:  2018-05       Impact factor: 7.598

2.  Comments on O'Brien et al.: prevalence and outcome of cirrhosis patients admitted to UK intensive care: a comparison against dialysis-dependent chronic renal failure patients.

Authors:  Nicholas P Mason; Andrew D Yeoman
Journal:  Intensive Care Med       Date:  2012-09-18       Impact factor: 17.440

3.  Comment on O'Brien et al.: prevalence and outcome of cirrhosis patients admitted to UK intensive care: a comparison against dialysis-dependent chronic renal failure patients.

Authors:  Philip A Berry; Sam J Thomson
Journal:  Intensive Care Med       Date:  2012-07-14       Impact factor: 17.440

4.  The ten tips to manage critically ill patients with acute-on-chronic liver failure.

Authors:  Valentin Fuhrmann; Tony Whitehouse; Julia Wendon
Journal:  Intensive Care Med       Date:  2018-01-31       Impact factor: 17.440

Review 5.  [Extracorporeal therapy of patients with liver disease in the intensive care unit].

Authors:  V Fuhrmann; T Horvatits; A Drolz; K Rutter
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-04-27       Impact factor: 0.840

6.  Factors that predict short-term intensive care unit mortality in patients with cirrhosis.

Authors:  Ranjeeta Bahirwani; Marwan Ghabril; Kimberly A Forde; Hemant Chatrath; Karen M Wolf; Lindsay Uribe; K Rajender Reddy; Barry Fuchs; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04-16       Impact factor: 11.382

7.  Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2.

Authors:  Alastair J O'Brien; James N Fullerton; Karen A Massey; Grace Auld; Gavin Sewell; Sarah James; Justine Newson; Effie Karra; Alison Winstanley; William Alazawi; Rita Garcia-Martinez; Joan Cordoba; Anna Nicolaou; Derek W Gilroy
Journal:  Nat Med       Date:  2014-04-13       Impact factor: 53.440

8.  Performance of Disease-Specific Scoring Models in Intensive Care Patients with Severe Liver Diseases.

Authors:  Maged T El-Ghannam; Moataz H Hassanien; Mohamed D El-Talkawy; Abdel Aziz A Saleem; Amal I Sabry; Hoda M Abu Taleb
Journal:  J Clin Diagn Res       Date:  2017-06-01

9.  Outcomes of chronic hemodialysis patients in the intensive care unit.

Authors:  Melanie Chan; Marlies Ostermann
Journal:  Crit Care Res Pract       Date:  2013-05-09

10.  Year in review in Intensive Care Medicine 2012: I. Neurology and neurointensive care, epidemiology and nephrology, biomarkers and inflammation, nutrition, experimentals.

Authors:  Massimo Antonelli; Marc Bonten; Maurizio Cecconi; Jean Chastre; Giuseppe Citerio; Giorgio Conti; J Randall Curtis; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Salvatore M Maggiore; Jordi Mancebo; Alexandre Mebazaa; Jean-Charles Preiser; Patricia Rocco; Jean-François Timsit; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2012-12-18       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.